Seroatlas · Human Serome Atlas

RFXANK

DNA-binding protein RFXANK

Also known as: ANKRA1, BLS, F14150_1, MGC138628, RFX-B, RFXK_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O14593
Gene
RFXANK
Ensembl
ENSG00000064490
Chromosome
19
Canonical length
260 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm
Quaternary structure
Homodimer

OverviewNCBI Gene

Major histocompatibility (MHC) class II molecules are transmembrane proteins that have a central role in development and control of the immune system. The protein encoded by this gene, along with regulatory factor X-associated protein and regulatory factor-5, forms a complex that binds to the X box motif of certain MHC class II gene promoters and activates their transcription. Once bound to the promoter, this complex associates with the non-DNA-binding factor MHC class II transactivator, which controls the cell type specificity and inducibility of MHC class II gene expression. This protein contains ankyrin repeats involved in protein-protein interactions. Mutations in this gene have been linked to bare lymphocyte syndrome type II, complementation group B. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2013]

Canonical amino-acid sequenceUniProt

260 residues, UniProt reviewed canonical sequence.

>O14593|RFXANK
     1  MELTQPAEDL IQTQQTPASE LGDPEDPGEE AADGSDTVVL SLFPCTPEPV NPEPDASVSS
    61  PQAGSSLKHS TTLTNRQRGN EVSALPATLD SLSIHQLAAQ GELDQLKEHL RKGDNLVNKP
   121  DERGFTPLIW ASAFGEIETV RFLLEWGADP HILAKERESA LSLASTGGYT DIVGLLLERD
   181  VDINIYDWNG GTPLLYAVRG NHVKCVEALL ARGADLTTEA DSGYTPMDLA VALGYRKVQQ
   241  VIENHILKLF QSNLVPADPE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RFXANK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.44
Highest tissue expression
39 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 39 nTPM
  • esophagus: 38 nTPM
  • kidney: 38 nTPM
  • spleen: 37 nTPM
  • thyroid gland: 36 nTPM
  • basal ganglia: 33 nTPM

Single-cell type

  • esophageal apical cells: 113 nCPM
  • megakaryocytes: 99 nCPM
  • hofbauer cells: 86 nCPM
  • esophageal suprabasal cells: 85 nCPM
  • extravillous trophoblasts: 77 nCPM
  • cytotrophoblasts: 75 nCPM

Immune cell

  • plasmacytoid DC: 54 nTPM
  • eosinophil: 52 nTPM
  • basophil: 49 nTPM
  • memory B-cell: 42 nTPM
  • naive B-cell: 42 nTPM
  • T-reg: 41 nTPM

Brain region

  • medulla oblongata: 29 nTPM
  • basal ganglia: 27 nTPM
  • white matter: 27 nTPM
  • cerebellum: 26 nTPM
  • hypothalamus: 25 nTPM
  • pons: 25 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RFXANK.

Disease | AllUniProt

Conditions RFXANK is implicated in, by any mechanism.

Disease | GeneticClinVar

33 pathogenic / likely-pathogenic of 332 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.12
gnomAD pLI
0
gnomAD missense Z
0.27
DepMap mean gene effect
-0.13
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of RFXANK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RFXANK as an antibody target. Whether an autoantibody or antibody against RFXANK could matter depends on whether native RFXANK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RFXANK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RFXANK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RFXANK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...